In marked contrast, mice treated with either oAd/APP or oAd/APP+DC combination showed significant inhibition of tumor growth in comparison to those treated with PBS or DC alone, resulting in complete tumor regression at day 27 following initial treatment (4/6 in oAd/APP and 6/6 in oAd/APP+DC group). This evidence concerns the gene APP and neoplasm.